The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection. Severe hypoglycemia occurs when a ...
from Google Alert - health https://ift.tt/2Yq29LM
via IFTTT
0 comments:
Post a Comment